Ftse Mib
33.766,29
-0,06%
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
NASDAQ
19.572,60
1,03%
Bitcoin
97.298,72
-0,47%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Vor Biopharma Inc (VOR) Vor Biopharma Inc (VOR) Notizie

Vor Biopharma Inc

VOR
0,90
0,0133 (1,50%)
21 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
09/12/202413:39EDGAR2Form 8-K - Current report
09/12/202413:30GLOBEVor Bio Provides Clinical Update Further Validating Approach..
14/11/202422:33EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
12/11/202414:00GLOBEVor Bio to Participate in the Stifel 2024 Healthcare..
08/11/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202422:05GLOBEVor Bio Reports Third Quarter 2024 Financial Results and..
07/11/202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05/11/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/11/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202422:16EDGAR2Form 3 - Initial statement of beneficial ownership of..
30/9/202413:05EDGAR2Form 8-K - Current report
30/9/202413:00GLOBEVor Bio Appoints Seasoned Healthcare Institutional Investor,..
05/9/202422:06EDGAR2Form 8-K - Current report
05/9/202422:01GLOBENew Clinical Data Validates Vor Bio’s Approach of Using..
04/9/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/9/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202422:01EDGAR2Form 8-K - Current report
28/8/202414:00GLOBEVor Bio to Participate in Upcoming Investor Conferences
08/8/202422:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202422:13EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
08/8/202422:05GLOBEVor Bio Reports Second Quarter 2024 Financial Results and..
08/8/202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05/8/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/8/202422:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
19/7/202423:04EDGAR2Form 144 - Report of proposed sale of securities
09/7/202422:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
10/6/202422:05EDGAR2Form 8-K - Current report
04/6/202422:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
28/5/202422:54EDGAR2Form 8-K - Current report
09/5/202422:05GLOBEVor Bio Reports First Quarter 2024 Financial Results and..
09/5/202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/5/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/5/202414:00GLOBEVor Bio to Participate in Upcoming Investor Conferences
03/5/202422:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
02/5/202422:01GLOBEVor Bio Appoints Accomplished Oncology and Cancer..
01/4/202414:00GLOBEVor Bio to Participate in Upcoming Investor Conferences
20/3/202421:05GLOBEVor Bio Reports Fourth Quarter and Full Year 2023 Financial..
05/3/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
04/3/202414:00GLOBEVor Bio to Participate in Upcoming Investor Conferences
14/2/202422:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202423:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202414:00GLOBEVor Bio to Participate in the Oppenheimer 34th Annual..
02/2/202422:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
01/2/202401:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 0,877499 Min: 0,8443 Max: 0,8817
Chiusura: 0,8867

La tua Cronologia

NASDAQ
VOR
Vor Biopharma
BIT
SJNK
SPDR Bloomberg SASB US H...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network